Pharmafile Logo
Pharmafocus logo
Advanced Search

paul workman

Showing 3 posts of 3 posts found.

Cancer image

Fixing what’s broken: why companies must prioritise innovation in drug development

March 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …

Feature
paul_workman

Institute of Cancer Research names chief executive

November 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICR, Institute of Cancer Research, paul workman

Professor Paul Workman has been appointed as the chief executive of the Institute of Cancer Research. Workman who also becomes …

Appointment
prof_paul_workman

Cancer drug discovery system ‘broken’

October 24, 2014
Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025